Agenus Valuation

AGEN Stock  USD 3.74  0.16  4.10%   
At this time, the firm appears to be overvalued. Agenus Inc shows a prevailing Real Value of $2.94 per share. The current price of the firm is $3.74. Our model approximates the value of Agenus Inc from analyzing the firm fundamentals such as profit margin of (1.42) %, and Return On Equity of -12.79 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Agenus' valuation include:
Price Book
218.6149
Enterprise Value
125.7 M
Enterprise Value Ebitda
(2.42)
Price Sales
0.5505
Enterprise Value Revenue
0.7835
Overvalued
Today
3.74
Please note that Agenus' price fluctuation is very risky at this time. Calculation of the real value of Agenus Inc is based on 3 months time horizon. Increasing Agenus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Agenus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Agenus Stock. However, Agenus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.74 Real  2.94 Target  8.0 Hype  3.74 Naive  3.14
The intrinsic value of Agenus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Agenus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.94
Real Value
9.37
Upside
Estimating the potential upside or downside of Agenus Inc helps investors to forecast how Agenus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Agenus more accurately as focusing exclusively on Agenus' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-3.62-3-2.6
Details
Hype
Prediction
LowEstimatedHigh
0.193.7410.17
Details
Naive
Forecast
LowNext ValueHigh
0.063.149.57
Details
5 Analysts
Consensus
LowTarget PriceHigh
7.288.008.88
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Agenus' intrinsic value based on its ongoing forecasts of Agenus' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Agenus' closest peers.

Agenus Cash

71.08 Million

Agenus Valuation Trend

Knowing Agenus' actual value is paramount for traders when making sound investment determinations. Using both Agenus' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Agenus Revenue by Product

Agenus Total Value Analysis

Agenus Inc is presently forecasted to have valuation of 125.69 M with market capitalization of 88.31 M, debt of 350.25 M, and cash on hands of 218.23 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Agenus fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
125.69 M
88.31 M
350.25 M
218.23 M

Agenus Investor Information

About 37.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 11.02. Agenus Inc last dividend was issued on the 29th of October 2010. The entity had 1:20 split on the 12th of April 2024. Based on the key indicators related to Agenus' liquidity, profitability, solvency, and operating efficiency, Agenus Inc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.

Agenus Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Agenus has an asset utilization ratio of 49.8 percent. This suggests that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Agenus Inc is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Agenus Ownership Allocation

Agenus holds a total of 23.61 Million outstanding shares. 30% of Agenus Inc outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Agenus Profitability Analysis

The company reported the previous year's revenue of 156.31 M. Net Loss for the year was (245.76 M) with loss before overhead, payroll, taxes, and interest of (28.68 M).

About Agenus Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Agenus Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Agenus Inc based exclusively on its fundamental and basic technical indicators. By analyzing Agenus's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Agenus's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Agenus. We calculate exposure to Agenus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Agenus's related companies.
Last ReportedProjected for Next Year
Gross Profit-73.2 M-69.6 M
Pretax Profit Margin(1.48)(1.56)
Operating Profit Margin(0.92)(0.96)
Net Loss(1.42)(1.49)
Gross Profit Margin(0.60)(0.63)

Agenus Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding17.9 M

Agenus Current Valuation Indicators

Agenus' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Agenus' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Agenus, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Agenus' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Agenus' worth.
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.